X
Record #62596

A synthetic peptide designed to neutralize lipopolysaccharides attenuates metaflammation and diet-induced metabolic derangements in mice

Publisher
Frontiers
Original paper date
Jul 18, 2021
Institution
William Harvey Research Institute, Bart’s and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom · Department of Basic Medical Sciences, School of Medicine, Al-Balqa Applied University, As-Salt, Jordan · Department of Drug Science and Technology, University of Turin, Turin, Italy · Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany · Septomics Research Center, Jena University Hospital, Jena, Germany · Sir William Dunn School Pathology, University of Oxford, Oxford, United Kingdom · Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy · IRCCS Multimedica, Sesto San Giovanni, Milan, Italy · Società Italiana per lo Studio della Aterosclerosi (S.I.S.A.) Centre for the Study of Atherosclerosis, Bassini Hospital, Milan, Italy · Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita´ degli Studi di Napoli “Federico II”, Napoli, Italy · Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany · Forschungszentrum Borstel, Department of Biophysics, Borstel, Germany · Brandenburg Antiinfektiva GmbH, c/o Forschungszentrum Borstel, Borstel, Germany · Department of Neurosciences “Rita Levi Montalcini”, University of Turin, Turin, Italy
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cellular(BLS) Nutrition
Citation lifecycle

How this paper is being cited

Pre-retraction
7
Same day
0
Post-retraction
0
% post-retraction
0.0%
~2.0 citations/yr before retraction · ~0.0 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse